Financials

News Discussions Technicals Forecast Seasonals

ELVN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Enliven Therapeutics, Inc.

Total assets of ELVN for Q2 24 is 327.04 M USD, 4.59% less than the previous Q1 24. And total liabilities decreased by 11.79% in Q2 24 to 22.11 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—